APA

Smook M. L. F., van Leeuwen M., Heeringa P., Damoiseaux J. G. M. C., Theunissen R., Daemen M. J. A. P., Lutgens E. & Tervaert J. W. C. (20081204). Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice. : Clinical and experimental immunology.

Chicago

Smook M L F, van Leeuwen M, Heeringa P, Damoiseaux J G M C, Theunissen R, Daemen M J A P, Lutgens E and Tervaert J W Cohen. 20081204. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice. : Clinical and experimental immunology.

Harvard

Smook M. L. F., van Leeuwen M., Heeringa P., Damoiseaux J. G. M. C., Theunissen R., Daemen M. J. A. P., Lutgens E. and Tervaert J. W. C. (20081204). Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice. : Clinical and experimental immunology.

MLA

Smook M L F, van Leeuwen M, Heeringa P, Damoiseaux J G M C, Theunissen R, Daemen M J A P, Lutgens E and Tervaert J W Cohen. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice. : Clinical and experimental immunology. 20081204.